MDWD MediWound: Net earnings per share for the last 12 months

The EPS (TTM) price chart for MediWound Ltd. (MDWD) demonstrates earnings dynamics that are currently at 3.80. The business is implementing eco-friendly fermentation methods and strictly adhering to bioethics. Stability is ensured by government contracts and the production of enzymes for ulcer therapy. The brand's competitiveness is bolstered by the NexoBrid patent, which enables efficient tissue cleansing for burns through exclusive agreements with military departments.
Financial and market metric breakdowns for MediWound (MDWD)

For MediWound Ltd. (MDWD), earnings per share growth reflects the efficiency of monetizing its expanding presence in the hospital segment and the integration of its products into international protocols. This indicator measures the percentage change in net income per share over a rolling year, which the EPS dynamics over the last 12 months year-over-year clearly demonstrate. The metric allows for an assessment of the real speed of business scaling, stripped of one-time factors. Investors should use this trend to confirm the sustainability of the company's profitability.